FP33-WE-02 Efficacy of natalizumab in second-line therapy of relapsing remitting multiple sclerosis: results from a multi-center study in German speaking countries

✍ Scribed by N. Putzki; Y. Oezguer; M. Mäurer; S. Cursiefen; S. Kuckert; V. Limmroth; M. Maschke; B. Tettenborn

• Book ID: 119467788
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 47 KB
• Volume: 285
• Category: Article
• ISSN: 0022-510X
• DOI: 10.1016/s0022-510x(09)70440-x